We’re proud to be featured in Applied Clinical Trials’ latest article spotlighting the future of pharmacovigilance: “Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance
Effective pharmacovigilance demands continuous monitoring of drug safety signals, a critical process that ensures accurate benefit-risk assessment while meeting global regulatory requirements. This paper examines
Written by Martin Holm-Petersen, Chief Strategy Officer Preamble This will be the first in a series of articles about the application of artificial intelligence (AI) and advanced
We are thrilled to share that Qinecsa’s Chief Strategy Officer, Martin Holm-Petersen, has been featured in IPI Journal’s article on the future of technology-led innovation
We are thrilled to share that Qinecsa’s Associate Vice President of Services Solutions, Dr Preeti Verma, has been featured in the latest edition of EPC
Using our PV Design Studio, Reportum offers configurable forms tailored to your use cases and workflows, allowing you to capture data from all sources. With
Pharmacovigilance is a critical component of the medicinal product lifecycle, focusing on ensuring the safety and efficacy of medicinal products from pre-clinical development through post-marketing
Call centres are typically responsible for a high percentage of safety report entry. However, the nature of the reporting process means it is hard to
Understanding patient safety is an essential element of Patient Support Programs. However, traditional safety reporting systems involve multi-step manual processes that often result in compliance
Safety reporting is not a core focus for field-based staff, therefore inputting of reports is often completed at a later time. This means report entry
2 Leman Street,
London, E1W 9US
United Kingdom
Company number: 13916274
